{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:41:00Z","timestamp":1772260860438,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00021"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00021"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Ovarian hyperstimulation syndrome (OHSS) is a rare, yet severe, iatrogenic complication of ovulation induction therapy during assisted reproductive procedures. Our group previously detected atypical cells in the ascitic fluid of OHSS patients, although no malignancy developed during follow up. Here, the aim was to perform a comparative analysis of the cytokines present in the abdominal fluid of patients affected by OHSS versus patients with advanced ovarian cancer, a benign adnexal mass, or ovarian endometriosis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This prospective, non-randomized study was conducted at the Clinical Center of the University of Pecs Department of Obstetrics and Gynecology\/Reproductive Center between October 2016 and March 2018. Abdominal fluid samples were obtained from 76 patients and subjected to Luminex analysis. The samples were collected from patients with OHSS (OHSS; <jats:italic>n<\/jats:italic>\u2009=\u200916), advanced ovarian cancer (OC; <jats:italic>n<\/jats:italic>\u2009=\u200922), a benign adnexal mass (BAM; <jats:italic>n<\/jats:italic>\u2009=\u200921), or ovarian endometriosis (EM; <jats:italic>n<\/jats:italic>\u2009=\u200917). Data were subjected to the non-parametric Kruskal-Wallis test and Spearman\u2019s rank correlation coefficient to identify statistical differences between the four study groups.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Leukocytosis and hemoconcentration were detected in the peripheral blood of OHSS patients. Abdominal fluid analysis further revealed significantly higher levels of interleukin (IL)-6, IL-8, IL-10, and transforming growth factor (TGF)-\u03b2 in both the OHSS and OC groups compared to the BAM and EM groups. The highest concentration of vascular endothelial growth factor (VEGF) was detected in the OC group, while a significantly lower level was detected in the OHSS group. Moreover, VEGF levels in OC and OHSS groups were significantly elevated compared to the levels in the BAM and EM groups.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Vasoactive and hematogenic cytokines were present at higher levels in both the OHSS and OC abdominal fluid samples compared to the fluid samples obtained from the peritoneal cavity of the BAM patients. It is possible that these cytokines play an important role in the formation of ascites.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13048-020-00624-9","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:09:25Z","timestamp":1583406565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0638-2057","authenticated-orcid":false,"given":"Balint","family":"Farkas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"Boldizsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Bohonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelli","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saska","family":"Marczi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor L.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozsef","family":"Bodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miklos","family":"Koppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"624_CR1","doi-asserted-by":"publisher","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","volume":"9","author":"MN Mascarenhas","year":"2012","unstructured":"Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9:e1001356.","journal-title":"PLoS Med"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/humupd\/dmu042","volume":"21","author":"F Lotti","year":"2014","unstructured":"Lotti F, Maggi M. \"ultrasound of the male genital tract in relation to male reproductive health\" (PDF). Hum Reprod Update. 2014;21:56\u201383.","journal-title":"Hum Reprod Update"},{"key":"624_CR3","unstructured":"Royal College of Obstetricians and Gynaecologists. The management of ovarian hyperstimulation syndrome. Green-top Guideline. 2006:5 Available at: http:\/\/www.rcog.org.uk\/resources\/Public\/pdf\/green_top_5_management_ohss_a.pdf. Accessed January 20 2009."},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1055\/s-0030-1265670","volume":"28","author":"R Gomez","year":"2010","unstructured":"Gomez R, Soares SR, Busso C, Garcia-Velasco JA, Simon C, Pellicer A. Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010;28:448\u201357.","journal-title":"Semin Reprod Med"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.01.085","volume":"93","author":"A V\u00e1rnagy","year":"2010","unstructured":"V\u00e1rnagy A, B\u00f3dis J, M\u00e1nfai Z, Wilhelm F, Buszny\u00e1k C, Kopp\u00e1n M. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertil Steril. 2010;93:2281\u20134.","journal-title":"Fertil Steril"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/08820139.2017.1360342","volume":"46","author":"MMM Sanguinete","year":"2017","unstructured":"Sanguinete MMM, Oliveira PH, Martins-Filho A, Micheli DC, Tavares-Murta BM, Murta EFC, Nomelini RS. Serum IL-6 and IL-8 correlate with prognostic factors in ovarian Cancer. Immunol Investig. 2017;46:677\u201388.","journal-title":"Immunol Investig"},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2019.1691222","volume":"22","author":"ISS Rodrigues","year":"2019","unstructured":"Rodrigues ISS, Martins-Filho A, Micheli DC, Lima CA, Tavares-Murta BM, Murta EFC, Nomelini RS. IL-6 and IL-8 as prognostic factors in peritoneal fluid of ovarian Cancer. Immunol Investig. 2019;22:1\u201312.","journal-title":"Immunol Investig"},{"key":"624_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10815-010-9387-6","volume":"27","author":"CO Nastri","year":"2010","unstructured":"Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27:121\u20138.","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 1","key":"624_CR9","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/S0049-3848(17)30070-1","volume":"151","author":"SM Nelson","year":"2017","unstructured":"Nelson SM. Prevention and management of ovarian hyperstimulation syndrome. Thromb Res. 2017;151(Suppl 1):S61\u20134.","journal-title":"Thromb Res"},{"key":"624_CR10","first-page":"106","volume":"20","author":"TN Sergentanis","year":"2014","unstructured":"Sergentanis TN, Diamantaras AA, Perlepe C, Kanavidis P, Skalkidou A, Petridou ET. IVF and breast cancer: a systematic review and meta-analysis. Hum ReprodUpdate. 2014;20:106\u201323.","journal-title":"Hum ReprodUpdate"},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clbc.2018.03.003","volume":"18","author":"R Taheripanah","year":"2018","unstructured":"Taheripanah R, Balash F, Anbiaee R, Mahmoodi M, Akbari Sene A. Breast cancer and ovulation induction treatments. Clin Breast Cancer. 2018;18:395\u20139.","journal-title":"Clin Breast Cancer"},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.rbmo.2015.03.008","volume":"31","author":"J Zhao","year":"2015","unstructured":"Zhao J, Li Y, Zhang Q, Wang Y. Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis. Reprod Biomed Online. 2015;31:20\u20139.","journal-title":"Reprod Biomed Online"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1477-7827-11-91","volume":"11","author":"I Hatzipetros","year":"2013","unstructured":"Hatzipetros I, Gocze PM, Cziraky K, Kovacs K, Kalman E, Farkas B. Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy. Reprod Biol Endocrinol. 2013;11:91\u20135.","journal-title":"Reprod Biol Endocrinol"},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/humrep\/12.12.2629","volume":"12","author":"RS Mathur","year":"1997","unstructured":"Mathur RS, Jenkins JM, Bansal AS. The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. Hum Reprod. 1997;12:2629\u201334.","journal-title":"Hum Reprod"},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0301-2115(99)00082-2","volume":"87","author":"MA Aboulghar","year":"1999","unstructured":"Aboulghar MA, Mansour RT, Serour GI, El Helw BA, Shaarawy M. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol. 1999;87:81\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0168-8278(92)90072-W","volume":"15","author":"T Andus","year":"1992","unstructured":"Andus T, Gross V, Holstege A, Weber M, Ott M, Gerok W, Sch\u00f6lmerich J. Evidence for the production of high amounts of interleukin-6 in the peritoneal cavity of patients with ascites. J Hepatol. 1992;15:378\u201381.","journal-title":"J Hepatol"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56:549\u201380.","journal-title":"Pharmacol Rev"},{"key":"624_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvq105","volume":"87","author":"DO Bates","year":"2010","unstructured":"Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovasc Res. 2010;87:262\u201371.","journal-title":"Cardiovasc Res"},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/humrep\/12.6.1129","volume":"12","author":"U Elchalal","year":"1997","unstructured":"Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod. 1997;12:1129\u201337.","journal-title":"Hum Reprod"},{"key":"624_CR20","first-page":"248","volume":"43","author":"B Namavar Jahromi","year":"2018","unstructured":"Namavar Jahromi B, Parsanezhad ME, Shomali Z, Bakhshai P, Alborzi M, Moin Vaziri N, Anvar Z. Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iran J Med Sci. 2018;43:248\u201360.","journal-title":"Iran J Med Sci"},{"key":"624_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0015-0282(16)58152-7","volume":"65","author":"JJ Krasnow","year":"1996","unstructured":"Krasnow JJ, Berga SL, Guzick DS, et al. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome. Fertil Steril. 1996;65:552\u20135.","journal-title":"Fertil Steril"},{"key":"624_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0015-0282(97)81908-5","volume":"67","author":"Y Abramov","year":"1997","unstructured":"Abramov Y, Barak V, Nisman B, Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril. 1997;67:261\u20135.","journal-title":"Fertil Steril"},{"key":"624_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2018.03.019","volume":"482","author":"V Dalal","year":"2018","unstructured":"Dalal V, Kumar R, Kumar S, Sharma A, Kumar L, Sharma JB, Roy KK, Singh N, Vanamail P. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients. Clin Chim Acta. 2018;482:27\u201332.","journal-title":"Clin Chim Acta"},{"key":"624_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0015-0282(99)00206-X","volume":"72","author":"CD Chen","year":"1999","unstructured":"Chen CD, Wu MY, Chen HF, Chen SU, Ho HN, Yang YS. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril. 1999;72:286\u201392.","journal-title":"Fertil Steril"},{"key":"624_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1006\/cyto.1997.0328","volume":"10","author":"L K\u00f6hidai","year":"1998","unstructured":"K\u00f6hidai L, Csaba G. Chemotaxis and chemotactic selection induced with cytokines (IL-8, RANTES and TNF-alpha) in the unicellular Tetrahymena pyriformis. Cytokine. 1998;10:481\u20136.","journal-title":"Cytokine"},{"key":"624_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0015-0282(16)58389-7","volume":"66","author":"A Revel","year":"1996","unstructured":"Revel A, Barak V, Lavy Y, Anteby E, Abramov Y, Schenker JJ, Amit A, Finci-Yeheskel Z, Mayer M, Simon A, Laufer N, Hurwitz A. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril. 1996;66:66\u201371.","journal-title":"Fertil Steril"},{"key":"624_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0301-2115(01)00396-7","volume":"99","author":"K Manolopoulos","year":"2001","unstructured":"Manolopoulos K, Lang U, Gips H, Braems GA. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol. 2001;99:226\u201331.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1215\/S1152851704001061","volume":"7","author":"DJ Brat","year":"2005","unstructured":"Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncology. 2005;7:122\u201333.","journal-title":"Neuro-Oncology"},{"key":"624_CR29","doi-asserted-by":"publisher","first-page":"e0175712","DOI":"10.1371\/journal.pone.0175712","volume":"12","author":"E Brencicova","year":"2017","unstructured":"Brencicova E, Jagger AL, Evans HG, Georgouli M, Laios A, Attard Montalto S, Mehra G, Spencer J, Ahmed AA, Raju-Kankipati S, Taams LS, Diebold SS. Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on toll-like receptor-mediated dendritic cell activation in ovarian carcinoma. PLoS One. 2017;12:e0175712.","journal-title":"PLoS One"},{"key":"624_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0015-0282(16)56283-9","volume":"60","author":"MA Friedlander","year":"1993","unstructured":"Friedlander MA. Loret de Mola JR, Goldfarb JM: elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril. 1993;60:826\u201333.","journal-title":"Fertil Steril"},{"key":"624_CR31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J. TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol. 2012;13:616\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"624_CR32","first-page":"804","volume":"108","author":"AD Santin","year":"2001","unstructured":"Santin AD, Bellone S, Ravaggi A, Roman J, Smith CV, Pecorelli S, Cannon MJ, Parham GP. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer. BJOG. 2001;108:804\u20138.","journal-title":"BJOG"},{"key":"624_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.fertnstert.2009.07.1662","volume":"94","author":"C Lisa","year":"2010","unstructured":"Lisa C. Grossman, Konstantinos G. Michalakis, hyacinth Browne, mark D. Payson, James H. Segars: the pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril. Author manuscript; available in PMC 2011 Jun 27. Fertil Steril. 2010;94:1392\u20138.","journal-title":"Fertil Steril"},{"issue":"7","key":"624_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1757-2215-7-55","volume":"16","author":"J B\u00f3dis","year":"2014","unstructured":"B\u00f3dis J, Papp S, Vermes I, Sulyok E, Tam\u00e1s P, Farkas B, Z\u00e1mb\u00f3 K, Hatzipetros I, Kov\u00e1cs GL. \"Platelet-associated regulatory system (PARS)\" with particular reference to female reproduction. J Ovarian Res. 2014;16(7):55\u201360.","journal-title":"J Ovarian Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-020-00624-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:23:45Z","timestamp":1614903825000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00624-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00624-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This prospective cohort study was approved by the University of Pecs Institutional Ethical Review Board (#5273\u20132\/2012). All of the participating patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The current manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The corresponding author (BF) and two other authors (JB and GLK) have multiple affiliations and JB has received financial support from the Hungarian Academy of Sciences (HAS; Budapest, Hungary). The remaining authors have no conflicts of interest to report regarding the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}